Gujarat Terce Laboratories Ltd. Share Price & Stock Analysis

Gujarat Terce Laboratories Ltd. (BSE: 524314) is an Ahmedabad, Gujarat-based company in the Pharmaceuticals industry. With a market capitalisation of ₹34 Cr, it ranks #4,078 by market cap among the 6,197 Indian listed companies on FinBizNet, and #53 of 63 in Pharmaceuticals. At ₹43.00 (as of 16 Nov 2026), the share price is 14.0% below its 52-week high of ₹50.00 and 48.3% above its 52-week low of ₹29.00. The share price is down 0.3% over one year and up 18.8% over three months.

Key Metrics

Current Price₹43.00
Market Cap₹34 Cr
BSE Code524314
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio14.7
Return on Equity27.14%
Return on Assets8.77%
52-Week Range₹29.00 – ₹50.00
1-Year Price Change-0.3%
3-Month Price Change+18.8%
Beta (1Y)0
HeadquartersAhmedabad, Gujarat
Websitewww.gujaratterce.in

Latest Quarterly Results — Q1 FY27

Revenue₹9 Cr
Net Profit₹-0 Cr
Net Margin-2.0%
EPS (Basic)₹0.23
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Gujarat Terce Laboratories Ltd. Quarterly Revenue and Profit Trend

Gujarat Terce Laboratories Ltd. reported revenue of ₹9 Cr in Q1 FY27, down 17.1% from ₹11 Cr in Q1 FY26 and down 21.1% from ₹11 Cr in Q4 FY26. It posted a net loss of ₹0 Cr for the quarter, against a net loss of ₹0 Cr in Q1 FY26. Across the 8 quarters from Q2 FY25 to Q1 FY27, quarterly revenue ranged from ₹9 Cr (Q1 FY27) to ₹13 Cr (Q2 FY25). The company reported a net loss in 3 of these 8 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹9 Cr−₹0 Cr−2.0%
Q4 FY26₹11 Cr₹0 Cr0.9%
Q3 FY26₹12 Cr₹1 Cr6.2%
Q2 FY26₹13 Cr₹1 Cr10.8%
Q1 FY26₹11 Cr−₹0 Cr−0.4%
Q4 FY25₹12 Cr−₹3 Cr−27.5%
Q3 FY25₹13 Cr₹1 Cr8.0%
Q2 FY25₹13 Cr₹1 Cr11.1%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 70.86% of Gujarat Terce Laboratories Ltd.'s shares as of Mar 2026, unchanged from Mar 2025. Delivery averaged 80.5% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Gujarat Terce Laboratories Ltd.

Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, Codimol, Cefter, and Terflora brands. Gujarat Terce Laboratories Limited was incorporated in 1985 and is based in Ahmedabad, India.

Products and Services

1. Pharmaceutical-This segment manufactures and markets medical and pharmaceutical preparations. It offers branded and generic formulations covering various therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrointestinal, anti-fungal, and others. 2. Metal-This segment manufactures copper sulphate. 3. Corporate-0 4. Segment Adjustment-0

Business Segments

1. Pharmaceutical-100%

Gujarat Terce Laboratories Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Gujarat Terce Laboratories Ltd.₹34 Cr14.727.14%₹9 Cr-0.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Gujarat Terce Laboratories Ltd.?

Gujarat Terce Laboratories Ltd. is trading at ₹43.00, with a market capitalisation of ₹34 Cr.

Which sector does Gujarat Terce Laboratories Ltd. belong to?

Gujarat Terce Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Gujarat Terce Laboratories Ltd.?

Gujarat Terce Laboratories Ltd. has a P/E of 14.7 and a return on equity of 27.14%.

What is the stock symbol of Gujarat Terce Laboratories Ltd.?

Gujarat Terce Laboratories Ltd. is listed on the BSE under the scrip code 524314.

How has Gujarat Terce Laboratories Ltd.'s share price moved over the past year?

Gujarat Terce Laboratories Ltd.'s share price is down 0.3% over one year and up 18.8% over three months. Its 52-week range is ₹29.00 to ₹50.00.

What were Gujarat Terce Laboratories Ltd.'s latest quarterly results?

In Q1 FY27, Gujarat Terce Laboratories Ltd. reported revenue of ₹9 Cr and net profit of ₹-0 Cr, with basic EPS of ₹0.23 (standalone, parsed from the company's exchange filing).

How have Gujarat Terce Laboratories Ltd.'s revenue and profit changed over the past year?

Gujarat Terce Laboratories Ltd. reported revenue of ₹9 Cr in Q1 FY27, down 17.1% from ₹11 Cr in Q1 FY26 and down 21.1% from ₹11 Cr in Q4 FY26.

What is the promoter holding in Gujarat Terce Laboratories Ltd.?

Promoters held 70.86% of Gujarat Terce Laboratories Ltd.'s shares as of Mar 2026, unchanged from Mar 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.